Clinical Presentations of Pediatric AD and Shin Guard Dermatitis

Peter Lio, MD, clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses how atopic dermatitis presents differently in pediatric patients, and the 2021 allergen of the year, acetophenone azine associated with shin guard dermatitis.

Related Videos
Related Content

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023
© 2023 MJH Life Sciences

All rights reserved.